Jiangsu Cancer Hospital (Jiangsu Institute of Cancer Research, the Affiliated Cancer Hospital of Nanjing Medical University) is a grade A class-three cancer hospital, which was derived from Jiangsu Hospital founded in 1960.It is the instruction center for cancer prevention, therapy, research and education in Jiangsu Province. It has been listed in the "Annual National Best Oncology Reputation Ranking" compiled by Hospital Management Institute of Fudan University for 6 consecutive years. In 2015, Jiangsu Cancer Hospital made its first appearance in the Top 100 Best Hospitals in China.

Jiangsu Cancer Hospital is State Institution of Drug Clinical Trials, the first batch of National Standardized Training Base for Resident Physicians and Standardized Cancer Pain Treatment Demonstration Ward announced by the Ministry of Health, Guidance Hospital for Standardized Treatment of Malignant Tumors in Municipalities and Counties announced by the Ministry of Health, National Postdoctoral Research Workstation, Jiangsu Cancer Specialist Nurse Training Base and Director Unit of Jiangsu Cancer Prevention and Control Alliance. In addition, Jiangsu Anti-cancer Association, Jiangsu Cancer Prevention and Control Office, Jiangsu Clinical Laboratory Center and Chinese Journal of Cancer Surgery are all located in the hospital.

Jiangsu Province Cancer Hospital, though located in Nanjing and not Shanghai, is renowned for its comprehensive cancer care and specialized medical services. The hospital excels in various oncology specialties, providing advanced diagnostic and treatment options for different types of cancers. Its medical oncology department is known for cutting-edge chemotherapy, targeted therapy, and immunotherapy treatments tailored to individual patient needs. The surgical oncology department offers minimally invasive and robotic-assisted surgeries, enhancing precision and recovery outcomes. The radiation oncology division utilizes state-of-the-art technologies such as intensity-modulated radiation therapy (IMRT) and stereotactic body radiation therapy (SBRT) for effective tumor targeting. Additionally, the hospital is distinguished in hematology, offering specialized care for blood cancers like leukemia and lymphoma. The comprehensive cancer care approach includes multidisciplinary teams comprising oncologists, surgeons, radiologists, and supportive care specialists who collaborate to develop personalized treatment plans. Furthermore, Jiangsu Province Cancer Hospital is committed to cancer research, participating in clinical trials and advancing knowledge in oncology. With its dedicated focus on cancer treatment and research, the hospital continues to be a leading institution in the fight against cancer in China.

Jiangsu Province Cancer Hospital, although located in Nanjing and not Shanghai, is committed to maintaining the highest standards of quality assurance to ensure exceptional patient care and safety. The hospital adheres to stringent national and international healthcare standards, undergoing regular accreditation and certification processes to validate its commitment to excellence. Its comprehensive quality management system includes continuous monitoring and evaluation of clinical outcomes, patient satisfaction, and operational efficiency. Routine audits, peer reviews, and adherence to evidence-based clinical guidelines are integral to its quality assurance practices. Jiangsu Province Cancer Hospital also places a strong emphasis on staff training and professional development, ensuring that healthcare providers are well-versed in the latest medical advancements and best practices. Advanced health information systems are utilized to enhance patient record accuracy, reduce errors, and facilitate seamless coordination of care. Through these robust quality assurance measures, Jiangsu Province Cancer Hospital consistently delivers safe, effective, and patient-centered oncology care, reinforcing its reputation as a leading cancer treatment and research institution in China.

Jiangsu Province Cancer Hospital, located in Nanjing rather than Shanghai, upholds a clear vision and mission to guide its commitment to excellence in cancer care.

Vision: Our vision at Jiangsu Province Cancer Hospital is to be a leading center of excellence in cancer treatment, research, and education, both nationally and internationally. We aspire to set new standards in oncology care, leveraging cutting-edge technology and innovative treatments to improve patient outcomes and quality of life. Through our dedication to pioneering research and collaborative efforts, we aim to contribute significantly to the global fight against cancer and establish ourselves as a beacon of hope for patients and their families.

Mission: Our mission is to provide comprehensive, patient-centered oncology care that meets the highest standards of quality and safety. We are committed to delivering compassionate and personalized treatment plans, integrating the latest scientific advancements and clinical practices. Jiangsu Province Cancer Hospital strives to foster a culture of continuous learning and professional development among our staff, ensuring that our medical professionals are at the forefront of cancer treatment and research. Additionally, we are dedicated to advancing medical knowledge through rigorous research and clinical trials, and to educating the next generation of healthcare professionals. By prioritizing patient well-being and embracing innovation, we aim to make a lasting impact on the fight against cancer and improve the health and lives of our community.

Jiangsu Province Cancer Hospital, located in Nanjing and not Shanghai, has garnered numerous awards and recognitions for its exceptional contributions to oncology care, research, and education. The hospital is consistently ranked among the top cancer treatment centers in China, reflecting its excellence in clinical outcomes and patient care. It has received prestigious accolades such as the "National Clinical Key Specialty Construction Project" designation from the Ministry of Health, recognizing its advanced capabilities in various oncology specialties. The hospital's commitment to quality and safety has earned it accreditation from the Joint Commission International (JCI), demonstrating its adherence to the highest global standards in healthcare. Additionally, Jiangsu Province Cancer Hospital has been honored with multiple national and provincial science and technology awards, highlighting its groundbreaking research and innovations in cancer treatment. The hospital's dedication to community service and public health initiatives has also been acknowledged through various awards for its efforts in cancer prevention, early detection, and education. These awards and recognitions underscore Jiangsu Province Cancer Hospital's unwavering commitment to excellence, innovation, and compassionate care, solidifying its reputation as a leading institution in the fight against cancer.